Roger is an American biochemist and professor of Structural Biology at Stanford University School of Medicine. He was awarded the Nobel Prize in Chemistry in 2006. His industry collaborations include partnerships with companies such as Teva Pharmaceuticals, ChromaDex, OphthaliX, Protalix Bio Therapeutics, Pacific Biosciences, and others. He holds a PhD in Chemical Physics from Stanford and a BA in Chemistry from Harvard University.